Amgen CEO Kevin Sharer to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Feb. 6, 2007--Amgen
(NASDAQ:AMGN) Chairman and CEO Kevin Sharer will present at the
Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device
Conference on Thursday, Feb. 8, 2007 beginning at 9:20 a.m. Eastern
Time. Live audio of the presentation will be available over the
Internet and can be accessed from Amgen's Web site, www.amgen.com,
Information regarding presentation time, webcast availability, and
webcast links are noted on Amgen's Investor Relations Events Calendar.
Amgen discovers, develops and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the
first companies to realize the new science's promise by bringing safe
and effective medicines from lab, to manufacturing plant, to patient.
Amgen therapeutics have changed the practice of medicine, helping
millions of people around the world in the fight against cancer,
kidney disease, rheumatoid arthritis, and other serious illnesses.
With a deep and broad pipeline of potential new medicines, Amgen
remains committed to advancing science to dramatically improve
people's lives. To learn more about our pioneering science and our
vital medicines, visit www.amgen.com.
CONTACT: Amgen, Thousand Oaks
David Polk, 805-447-4613 or 805-490-0661 (media)
Arvind Sood, 805-447-1060 (investors)